231 related articles for article (PubMed ID: 11784216)
1. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.
Jensen AG; Wachmann CH; Espersen F; Scheibel J; Skinhøj P; Frimodt-Møller N
Arch Intern Med; 2002 Jan; 162(1):25-32. PubMed ID: 11784216
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
Nissen JL; Skov R; Knudsen JD; Ostergaard C; Schønheyder HC; Frimodt-Møller N; Benfield T
J Antimicrob Chemother; 2013 Aug; 68(8):1894-900. PubMed ID: 23599360
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus bacteremia.
Jensen AG
Dan Med Bull; 2003 Nov; 50(4):423-38. PubMed ID: 14694855
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study.
Braquet P; Alla F; Cornu C; Goehringer F; Piroth L; Chirouze C; Revest M; Lechiche C; Duval X; Le Moing V;
Clin Microbiol Infect; 2016 Nov; 22(11):948.e1-948.e7. PubMed ID: 27515395
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.
Fätkenheuer G; Preuss M; Salzberger B; Schmeisser N; Cornely OA; Wisplinghoff H; Seifert H
Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):157-62. PubMed ID: 14986158
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
Laupland KB; Ross T; Gregson DB
J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
[TBL] [Abstract][Full Text] [Related]
7. Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit.
Kuint J; Barzilai A; Regev-Yochay G; Rubinstein E; Keller N; Maayan-Metzger A
Eur J Pediatr; 2007 Apr; 166(4):319-25. PubMed ID: 17051356
[TBL] [Abstract][Full Text] [Related]
8. Community-acquired Staphylococcus aureus bacteremia: Studies of risk and prognosis with special attention to diabetes mellitus and chronic heart failure.
Smit J
Dan Med J; 2017 May; 64(5):. PubMed ID: 28552097
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus bacteremia: comparison of two periods and a predictive model of mortality.
de Oliveira Conterno L; Wey SB; Castelo A
Braz J Infect Dis; 2002 Dec; 6(6):288-97. PubMed ID: 12585972
[TBL] [Abstract][Full Text] [Related]
10. [Methicillin susceptible Staphylococcus aureus bacteremia: epidemiology and prognostic factors. A prospective study 2000-2003].
Gómez J; García-Vázquez E; Baños R; Canteras M; Ruiz J; Herrero JA; Baños V; Valdés M
Rev Clin Esp; 2007 Feb; 207(2):57-63. PubMed ID: 17397563
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology, course and prognosis of Staphylococcus aureus bacteremia--Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort].
Seifert H; Wisplinghoff H; Kaasch A; Achilles K; Langhorst A; Peyerl-Hoffmann G; Woehrmann A; Fätkenheuer G; Salzberger B; Kern WV
Dtsch Med Wochenschr; 2008 Feb; 133(8):340-5. PubMed ID: 18270913
[TBL] [Abstract][Full Text] [Related]
12. Resurgence of penicillin-susceptible Staphylococcus aureus at a hospital in New York State, USA.
Crane JK
J Antimicrob Chemother; 2014 Jan; 69(1):280-1. PubMed ID: 23925938
[No Abstract] [Full Text] [Related]
13. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
[TBL] [Abstract][Full Text] [Related]
14. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus.
Romero-Vivas J; Rubio M; Fernandez C; Picazo JJ
Clin Infect Dis; 1995 Dec; 21(6):1417-23. PubMed ID: 8749626
[TBL] [Abstract][Full Text] [Related]
15. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
Lesens O; Methlin C; Hansmann Y; Remy V; Martinot M; Bergin C; Meyer P; Christmann D
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):890-6. PubMed ID: 14700403
[TBL] [Abstract][Full Text] [Related]
16. Thirty-day mortality in UK patients with community-onset and hospital-acquired meticillin-susceptible Staphylococcus aureus bacteraemia.
Melzer M; Welch C
J Hosp Infect; 2013 Jun; 84(2):143-50. PubMed ID: 23602415
[TBL] [Abstract][Full Text] [Related]
17. Comparison of outcome and clinical characteristics of bacteremia caused by methicillin-resistant, penicillin-resistant and penicillin-susceptible Staphylococcus aureus strains.
Jokinen E; Laine J; Huttunen R; Rahikka P; Huhtala H; Vuento R; Vuopio J; Syrjänen J
Infect Dis (Lond); 2017 Jul; 49(7):493-500. PubMed ID: 28276799
[TBL] [Abstract][Full Text] [Related]
18. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia.
Hounsom L; Grayson K; Melzer M
Postgrad Med J; 2011 Nov; 87(1033):757-62. PubMed ID: 21798969
[TBL] [Abstract][Full Text] [Related]
19. Back to the Future: Penicillin-Susceptible Staphylococcus aureus.
Cheng MP; René P; Cheng AP; Lee TC
Am J Med; 2016 Dec; 129(12):1331-1333. PubMed ID: 26924388
[TBL] [Abstract][Full Text] [Related]
20. Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs.
Willcox PA; Rayner BL; Whitelaw DA
QJM; 1998 Jan; 91(1):41-7. PubMed ID: 9519211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
